http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg#head http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg#assertion http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg#provenance http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg#publicationInfo http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg#assertion http://bio2rdf.org/drugbank:DB00176 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00176_DB00395 http://bio2rdf.org/drugbank:DB00395 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00176_DB00395 http://bio2rdf.org/drugbank_resource:DB00176_DB00395 http://purl.org/dc/terms/identifier drugbank_resource:DB00176_DB00395 http://bio2rdf.org/drugbank_resource:DB00176_DB00395 http://purl.org/dc/terms/title DDI between Fluvoxamine and Carisoprodol - Strong CYP2C19 inhibitors such as fluvoxamine may decrease the metabolism of CYP2C19 substrates such as carisoprodol. Consider an alternative for one of the interacting drugs in order to avoid toxicity of the substrate. Some combinations are specifically contraindicated by manufacturers. Suggested dosage adjustments are also offered by some manufacturers. Please review applicable package inserts. Monitor for increased effects of the CYP substrate if a CYP inhibitor is initiated/dose increased, and decreased effects if a CYP inhibitor is discontinued/dose decreased. http://bio2rdf.org/drugbank_resource:DB00176_DB00395 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00176_DB00395 http://www.w3.org/2000/01/rdf-schema#label DDI between Fluvoxamine and Carisoprodol - Strong CYP2C19 inhibitors such as fluvoxamine may decrease the metabolism of CYP2C19 substrates such as carisoprodol. Consider an alternative for one of the interacting drugs in order to avoid toxicity of the substrate. Some combinations are specifically contraindicated by manufacturers. Suggested dosage adjustments are also offered by some manufacturers. Please review applicable package inserts. Monitor for increased effects of the CYP substrate if a CYP inhibitor is initiated/dose increased, and decreased effects if a CYP inhibitor is discontinued/dose decreased. [drugbank_resource:DB00176_DB00395] http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg#provenance http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg#publicationInfo http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg#signature.MCwCFCMIV4SHI4LD http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg#signature.MCwCFCMIV4SHI4LD http://purl.org/nanopub/x/hasSignature MCwCFCMIV4SHI4LDGL9iD9Vdf4E7LU2wAhRFDMZ+PSfiFtQMfQSsfchCIh/V2A== http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg#signature.MCwCFCMIV4SHI4LD http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg http://purl.org/dc/terms/created 2018-03-30T11:13:08.970+02:00 http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg#signature.MCwCFCMIV4SHI4LD http://bio2rdf.org/drugbank_resource:DB00176_DB00395_nanopub.RA4UgY7vSkSckUfDuTM0GCH6heMSpwFITVCQMXHVkDZsg http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234